Avingtrans upgrades FY25 outlook with stronger EBITDA performance

Avingtrans plc

Avingtrans PLC (LON:AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, has announced an update on current trading ahead of conclusion of the financial year ending 31 May 2025.

Based on unaudited management accounts for FY25, the Company now expects to report Adj. EBITDA¹ ahead of market expectations², driven by better than anticipated performance within the Advanced Engineering Systems (AES) division. Revenues are expected to be in-line2.

Avingtrans intends to provide a more detailed update on current performance by way of a trading update to be published in mid June 2025.

ÂąAdjusted to add back amortisation of intangibles from business combinations, acquisition costs and exceptional items and discontinued operations.

² Prior to today’s announcement, the Company understands that market expectations for FY25 were Revenues of ÂŁ161.0m and

Adj. EBITDA of ÂŁ15.1m.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

UK quantum strategy highlights opportunity for specialist magnet systems

UK plans to scale quantum computing highlight the role of specialist superconducting magnet systems in supporting the sector’s move towards commercial deployment.

Adaptix gains market access milestone with Ortho350 certification

Adaptix has secured CE certification for Ortho350, giving the company a clearer route into UK and European orthopaedic imaging markets.

Booth Industries demonstrated safety-critical rail capability on HS1

Booth Industries’ HS1 delivery highlighted its ability to provide reliable, safety-critical tunnel systems for major rail infrastructure.

Avingtrans builds quantum supply chain opportunity

Avingtrans subsidiary Scientific Magnetics has shipped its 20th quantum computing magnet, with 18 more in production, strengthening its role in the quantum technology supply chain.

Avingtrans Secures Major Medical Milestone With Adaptix CE Certification, Singer Capital Markets

Avingtrans secures CE certification for Adaptix Ortho350, strengthening commercial opportunities in Europe and supporting long term medical growth ambitions.

Avingtrans’ Adaptix Ortho350 receives CE certification

Adaptix can now commercialise its compact 3D orthopaedic imaging system across UK and European healthcare markets.

Search